Embecta Corp. (EMBC) Stock Analysis

What Embecta Corp. does

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

Key metrics

ETFs linked to EMBC

Broad-market and Healthcare sector ETFs an investor holding Embecta Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EMBC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Embecta Corp.?

Embecta Corp. trades under the ticker EMBC on NASDAQ.

Which exchange is EMBC listed on?

EMBC is listed on NASDAQ.

What sector does Embecta Corp. operate in?

Embecta Corp. is classified in the Healthcare sector (Medical - Instruments & Supplies industry).

How can PortView help analyze EMBC in a portfolio?

PortView shows EMBC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.